PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
July 3, 2026Journal of Cancer Research and Clinical OncologyOpen Access

Nano-biosensors for circulating tumor markers: advancing liquid biopsy toward precision cancer diagnostics

View Full Paper
Ask AI
Bookmark
Share

Authors

TBTaranga Jyoti BaruahJBJutishna BoraRMRicha Mishra

Discussion

Loading...

Member takes

Overview

Review highlights advances in nano-biosensors for detecting circulating tumor markers, suggesting improved cancer diagnostics.

Key Points

  • This review aims to summarize advancements in nano-biosensors for detecting circulating tumor markers (CTMs) and their impact on cancer diagnostics.
  • Reviewed recent studies on nano-biosensor platforms for CTM detection.
  • Examined electrochemical, optical, plasmonic, and microfluidic-integrated systems.
  • Evaluated the use of advanced nanomaterials for signal enhancement and target recognition.
  • Nano-biosensors showed improved sensitivity, specificity, and biomarker selectivity for CTM detection.
  • Integration with microfluidic technologies allowed multiplexed and rapid detection of CTMs.
  • Emerging lab-on-a-chip and wearable biosensors demonstrated potential for real-time monitoring and decentralized testing.

Cite This Study

Baruah et al. (2026) studied this question.

synapsesocial.com/papers/6a4750b55c29257aa257854bhttps://doi.org/10.1007/s00432-026-06532-7
View Full Paper
Ask AI
Bookmark
Share